“Biomarker-Guided Oncology Practice in Non–Small Cell Lung Cancer: Utilization Patterns, Turnaround Time, and Sector-Associated Access Barriers” (2025) Journal of Precision Medicine and Health Research, 2(2), p. e20. doi:10.61919/p8kycn81.